Universal Ibogaine Announces Granting of Management Cease Trade Order
Calgary, AB – TheNewswire - December 11, 2023 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that its application for a temporary management case trade order (“MCTO”) has been granted by the Alberta Securities Commission (the “ASC”, as Principal Regulator). UI previously advised (see prior news releases [...]